Skip to main content

Congestive Heart Failure News (Page 4)

New 'AI Stethoscope' Can Spot Pregnancy-Linked Heart Failure

THURSDAY, Sept. 5, 2024 – An AI-enhanced digital stethoscope can help doctors detect a potentially deadly form of heart failure that can occur late in pregnancy, a new clinical trial reports. The...

Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find

FRIDAY, Aug.30, 2024 – New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways. These two injected drugs are versions of...

Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure

WEDNESDAY, Aug. 28, 2024 – Semaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or...

Wegovy Helps Patients With Heart Failure Avoid Heart Attack, Stroke

FRIDAY, Aug. 23, 2024 – Research has already proven that the blockbuster weight-loss drug Wegovy (semaglutide) can slash a person's odds for heart attacks and strokes, and now more data from the...

Study Reveals Heart Failure Risks in American Indian Communities

THURSDAY, Aug. 22, 2024 – A study published online Aug. 21 in the Journal of the American Heart Association reveals the major contributors to heart failure risk in American Indians, highlighting the...

Mitral Valve Surgery Linked to Lower Rates of Adverse Outcomes in AFMR

THURSDAY, Aug. 22, 2024 – For patients with atrial functional mitral regurgitation (AFMR), mitral valve (MV) surgery is associated with lower rates of adverse clinical outcomes, according to a study...

CMR-Modeled PCWP Independent Risk Factor for Heart Failure

THURSDAY, Aug. 22, 2024 – Elevated cardiovascular magnetic resonance (CMR) imaging-modeled pulmonary capillary wedge pressure (PCWP) is an independent risk factor for heart failure and major adverse...

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication in Heart Failure

Furoscix is now indicated for the treatment of congestion due to fluid overload in adult patients with chronic heart failure, regardless of New York Heart Association (NYHA) functional class...

Follow-Up Has Improved for AMI, Heart Failure Hospitalization

MONDAY, Aug. 5, 2024 – Follow-up has improved for patients with acute myocardial infarction (AMI) and heart failure, but disparities persist in follow-up rates, according to a study published online...

Digoxin, Beta-Blockers Have Equivalent Effects on Heart Rate in A-Fib

TUESDAY, July 23, 2024 – For patients with atrial fibrillation, digoxin and beta-blockers have equivalent effects on heart rate at rest and on exertion, according to a study published online July 15...

Large Geographic Variation Seen With Heart Failure Phenotypes

THURSDAY, July 18, 2024 – There is substantial geographic variation in patient characteristics, treatment, and outcomes among patients with heart failure with preserved ejection fraction (HFpEF) or...

Second Recipient of Genetically Modified Pig Kidney Has Died

WEDNESDAY, July 10, 2024 – The second person to receive a kidney from a genetically modified pig has died, surgeons at NYU Langone Health announced Tuesday. The 54-year-old patient, Lisa Pisano, had...

FDA Approves Entresto (sacubitril/valsartan) for Heart Failure

July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of...

FDA Medwatch Alert: Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates

ISSUE: Hospira, Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 mg, 20 mL, Single-dose fliptop vial, (NDC 0409-2344-02), Lot 27-352-DK. (NDC and lot...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Left Ventricular Dysfunction, Cardiovascular Conditions and Disorders

Related drug support groups

lisinopril, metoprolol, warfarin, spironolactone, Coumadin, triamcinolone, carvedilol, Metoprolol Succinate ER, diltiazem, view more... Lasix, furosemide, Entresto, bisoprolol, valsartan, Farxiga, Jardiance, ramipril, digoxin, prazosin, Diovan, nitroglycerin, Coreg